Chemomab Therapeutics Statistics
Total Valuation
CMMB has a market cap or net worth of $25.68 million. The enterprise value is $15.03 million.
| Market Cap | 25.68M |
| Enterprise Value | 15.03M |
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CMMB has 19.16 million shares outstanding. The number of shares has increased by 60.31% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.16M |
| Shares Change (YoY) | +60.31% |
| Shares Change (QoQ) | +20.95% |
| Owned by Insiders (%) | 15.28% |
| Owned by Institutions (%) | 10.42% |
| Float | 13.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.40 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.33, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.33 |
| Quick Ratio | 5.27 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -112.97% and return on invested capital (ROIC) is -72.62%.
| Return on Equity (ROE) | -112.97% |
| Return on Assets (ROA) | -57.49% |
| Return on Invested Capital (ROIC) | -72.62% |
| Return on Capital Employed (ROCE) | -134.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$670,000 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.23% in the last 52 weeks. The beta is 0.63, so CMMB's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +25.23% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 53.71 |
| Average Volume (20 Days) | 107,010 |
Short Selling Information
| Short Interest | 77,106 |
| Short Previous Month | 122,745 |
| Short % of Shares Out | 0.41% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.81 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.18M |
| Pretax Income | -19.36M |
| Net Income | -13.40M |
| EBITDA | -14.13M |
| EBIT | -14.18M |
| Earnings Per Share (EPS) | -$0.67 |
Balance Sheet
The company has $10.56 million in cash and $292,000 in debt, giving a net cash position of $10.27 million or $0.54 per share.
| Cash & Cash Equivalents | 10.56M |
| Total Debt | 292,000 |
| Net Cash | 10.27M |
| Net Cash Per Share | $0.54 |
| Equity (Book Value) | 10.39M |
| Book Value Per Share | 0.55 |
| Working Capital | 9.73M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMMB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.31% |
| Shareholder Yield | -60.31% |
| Earnings Yield | -52.97% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CMMB is $8.50, which is 534.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.50 |
| Price Target Difference | 534.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -57.96% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |